nad has been researched along with Aura in 19 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 9 (47.37) | 18.7374 |
| 1990's | 1 (5.26) | 18.2507 |
| 2000's | 4 (21.05) | 29.6817 |
| 2010's | 4 (21.05) | 24.3611 |
| 2020's | 1 (5.26) | 2.80 |
| Authors | Studies |
|---|---|
| Devinsky, O; Devore, S; Friedman, D; Jones, DR; Kanshin, E; Korman, A; Leitner, DF; Lin, Z; Siu, Y; Tsirigos, A; Ueberheide, B; Wisniewski, T | 1 |
| Cao, L; Chi, Z; Li, H; Lin, Y; Liu, X; Pang, Y; Qiu, X; Wang, S; Wang, X; Yang, X; Zhao, X | 1 |
| Horn, P; Miles, L; Miles, MV; Rozhkov, L; Tenney, JR | 1 |
| Bernard, C; Ivanov, AI; Turner, DA | 1 |
| Cha, SS; Cheng, CH; Fong, WP; Lam, YM; Tang, WK; Wong, KB | 1 |
| Day, BJ; Huang, TT; Liang, LP; Patel, M; Rowley, S; Waldbaum, S | 1 |
| Bergendahl, K; Daley, TJ; Garriga-Canut, M; Morrison, JF; Ockuly, J; Pfender, RM; Qazi, R; Roopra, A; Schoenike, B; Stafstrom, C; Sutula, T | 1 |
| Grover, WD; Hardison, HH; Hobdell, EF; Khurana, DS; Legido, A; Marks, HG; Melvin, JJ; Salganicoff, L; Valencia, I | 1 |
| Dóra, E; Koller, A; Kovách, AG | 1 |
| Dóra, E | 1 |
| Hassinen, IE; Majamaa, K; Pyhtinen, J; Remes, AM; Rusanen, H | 1 |
| Mayevsky, A; Yoles, E; Zarchin, N; Zurovsky, Y | 1 |
| Lewis, DV; Schuette, WH | 1 |
| Fischer, JC; Gabreëls, FJ; Janssen, AJ; Renier, WO; Ruitenbeek, W; Sengers, RC; Stadhouders, AM; ter Laak, HJ; Trijbels, JM; Veerkamp, JH | 1 |
| Herman, CJ; Lewis, DV; O'Connor, MJ | 1 |
| Chesielski, L; Kempf, E; Lehmann, A; Maitre, M; Mandel, P | 1 |
| Liang, HS; Smith, JS; Thurston, JH; Valentini, EJ | 1 |
| Herman, CJ; Jöbsis, FF; O'Connor, MJ; Rosenthal, M | 1 |
| Duffy, TE; Howse, DC; Plum, F | 1 |
19 other study(ies) available for nad and Aura
| Article | Year |
|---|---|
Metabolomic, proteomic, and transcriptomic changes in adults with epilepsy on modified Atkins diet.
Topics: 3-Hydroxybutyric Acid; Adult; Diet, Carbohydrate-Restricted; Diet, High-Protein Low-Carbohydrate; Diet, Ketogenic; Epilepsy; Humans; Infant, Newborn; Ketone Bodies; Middle Aged; NAD; Proteomics; Seizures; Transcriptome; Treatment Outcome | 2023 |
Cellular NAD depletion and decline of SIRT1 activity play critical roles in PARP-1-mediated acute epileptic neuronal death in vitro.
Topics: Animals; Apoptosis Inducing Factor; Cell Death; Epilepsy; Hippocampus; NAD; Neurons; Poly (ADP-Ribose) Polymerase-1; Poly(ADP-ribose) Polymerases; Rats; Sirtuin 1 | 2013 |
Cerebral glucose hypometabolism is associated with mitochondrial dysfunction in patients with intractable epilepsy and cortical dysplasia.
Topics: Adolescent; Cerebral Cortex; Child; Child, Preschool; Electroencephalography; Electron Transport Complex IV; Epilepsy; Female; Fluorodeoxyglucose F18; Glial Fibrillary Acidic Protein; Humans; Male; Malformations of Cortical Development; Mitochondrial Diseases; NAD; Positron-Emission Tomography; Proto-Oncogene Proteins c-akt; Retrospective Studies | 2014 |
Metabolic responses differentiate between interictal, ictal and persistent epileptiform activity in intact, immature hippocampus in vitro.
Topics: Animals; Animals, Newborn; Bicuculline; Convulsants; Epilepsy; Flavin-Adenine Dinucleotide; GABA-A Receptor Antagonists; Hippocampus; Ions; Magnesium; Mice; Microelectrodes; NAD; Oxygen; Receptors, GABA-A; Tissue Culture Techniques | 2015 |
The crystal structure of seabream antiquitin reveals the structural basis of its substrate specificity.
Topics: 2-Aminoadipic Acid; Aldehyde Dehydrogenase; Animals; Crystallography, X-Ray; Epilepsy; Fish Proteins; Humans; Mutation; NAD; Protein Conformation; Pyridoxine; Sea Bream; Substrate Specificity | 2008 |
Mitochondrial oxidative stress and epilepsy in SOD2 deficient mice: attenuation by a lipophilic metalloporphyrin.
Topics: Aconitate Hydratase; Adenine Nucleotides; Analysis of Variance; Animals; Animals, Newborn; Anticonvulsants; Cerebral Cortex; Chromatography, High Pressure Liquid; Coenzyme A; Disease Models, Animal; Electroencephalography; Epilepsy; Fumarate Hydratase; Glutathione; Glutathione Disulfide; Metalloporphyrins; Mice; Mice, Inbred C57BL; Mice, Knockout; Mitochondria; NAD; Oxidative Stress; Superoxide Dismutase; Tyrosine | 2012 |
2-Deoxy-D-glucose reduces epilepsy progression by NRSF-CtBP-dependent metabolic regulation of chromatin structure.
Topics: Alcohol Oxidoreductases; Animals; Antimetabolites; Chromatin; Deoxyglucose; Diet; Disease Progression; DNA-Binding Proteins; Down-Regulation; Energy Metabolism; Epilepsy; Gene Expression; Glycolysis; Hippocampus; Kindling, Neurologic; NAD; Neuronal Plasticity; Rats; Receptor, trkB; Repressor Proteins; Transcription Factors | 2006 |
Epilepsy and respiratory chain defects in children with mitochondrial encephalopathies.
Topics: Adolescent; Child; Child, Preschool; Cytochromes; Electroencephalography; Electron Transport; Electron Transport Complex I; Electron Transport Complex III; Electron Transport Complex IV; Epilepsy; Female; Follow-Up Studies; Humans; Infant; Infant, Newborn; Male; Mitochondria, Muscle; Mitochondrial Encephalomyopathies; NAD; Oxidative Stress; Retrospective Studies | 2008 |
Effect of topical adenosine deaminase treatment on the functional hyperemic and hypoxic responses of cerebrocortical microcirculation.
Topics: Adenosine Deaminase; Administration, Topical; Animals; Blood Volume; Cats; Cerebral Cortex; Electric Stimulation; Epilepsy; Hyperemia; Hypoxia; Male; Microcirculation; NAD; Nucleoside Deaminases; Oxidation-Reduction; Time Factors; Vasodilation | 1984 |
Glycolysis and epilepsy-induced changes in cerebrocortical NAD/NADH redox state.
Topics: Animals; Cats; Cerebral Cortex; Electron Transport; Epilepsy; Fluorometry; Glycolysis; Male; NAD | 1983 |
Increase of blood NAD+ and attenuation of lactacidemia during nicotinamide treatment of a patient with the MELAS syndrome.
Topics: Aged; Anticonvulsants; Carbamazepine; Cells, Cultured; Cerebrovascular Disorders; Epilepsy; Fibroblasts; Humans; Kinetics; Lactates; Male; MELAS Syndrome; Mitochondria, Muscle; NAD; NAD(P)H Dehydrogenase (Quinone); Niacinamide; Oxygen Consumption; Skin | 1996 |
The effect of hyperbaric hyperoxia on brain function in the newborn dog in vivo.
Topics: Age Factors; Animals; Animals, Newborn; Brain; Cerebrovascular Circulation; Dogs; Electroencephalography; Epilepsy; Hyperbaric Oxygenation; Hyperoxia; Mitochondria; NAD; Oxidation-Reduction; Oxygen; Seizures | 2000 |
NADH fluorescence and [K+]o changes during hippocampal electrical stimulation.
Topics: Animals; Cats; Electric Stimulation; Epilepsy; Fluorescence; Fluorometry; Hippocampus; Membrane Potentials; Microelectrodes; NAD; Oxidation-Reduction; Oxygen Consumption; Potassium; Time Factors | 1975 |
A mitochondrial encephalomyopathy: the first case with an established defect at the level of coenzyme Q.
Topics: Acidosis; Adenosine Triphosphate; Brain Diseases; Epilepsy; Humans; Infant; Intellectual Disability; Lactates; Male; Mitochondria, Muscle; Muscle Spasticity; Myoclonus; NAD; Nystagmus, Pathologic; Oxidation-Reduction; Pyruvates; Ubiquinone | 1986 |
Effects of potassium on oxidative metabolism and seizures.
Topics: Animals; Cats; Electroencephalography; Epilepsy; Fluorescence; Hippocampus; NAD; Oxygen Consumption; Potassium | 1973 |
Protective effect of adenosine and nicotinamide against audiogenic seizure.
Topics: Acoustic Stimulation; Adenosine; Adenosine Triphosphate; Animals; Blood Pressure; Brain Chemistry; Caffeine; Dose-Response Relationship, Drug; Electroencephalography; Epilepsy; gamma-Aminobutyric Acid; Hypnotics and Sedatives; Male; Mice; Mice, Inbred Strains; NAD; Niacinamide; Norepinephrine; Phosphocreatine; Phosphorus Radioisotopes; Time Factors | 1974 |
New enzymatic method for measurement of paraldehyde: correlation of effects with serum and CSF levels.
Topics: Alcohol Oxidoreductases; Anticonvulsants; Child; Child, Preschool; Epilepsy; Humans; Hypnotics and Sedatives; Infant; Infant, Newborn; Methods; NAD; Paraldehyde | 1968 |
Intracellular redox changes preceding onset of epileptiform activity in intact cat hippocampus.
Topics: Animals; Blood Volume; Carbon Dioxide; Cats; Electroencephalography; Epilepsy; Female; Hippocampus; Hypoxia; Male; Mitochondria; NAD; Oxidation-Reduction; Oxygen; Penicillins; Ultraviolet Rays | 1972 |
Metabolic effects of seizures.
Topics: Acidosis; Adenosine Diphosphate; Adenosine Triphosphate; Animals; Bicarbonates; Blood Flow Velocity; Brain; Carbon Dioxide; Cats; Cerebrovascular Circulation; Dogs; Electric Stimulation; Energy Metabolism; Epilepsy; Flurothyl; Hydrogen-Ion Concentration; Lactates; Mice; NAD; Oxygen; Oxygen Consumption; Pentylenetetrazole; Phosphocreatine; Pyruvates; Rats; Seizures | 1974 |